Related Experiment Video
Updated: Jun 4, 2026
08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Genetic susceptibility to occupational contact dermatitis
1Coronel Institute of Occupational Health, Academic Medical Center, University of Amsterdam, The Netherlands. s.kezic@amc.uva.nl
International Journal of Immunopathology and Pharmacology
|February 19, 2011
Summary
Genetic variations influence susceptibility to occupational contact dermatitis (CD). While filaggrin mutations and specific gene polymorphisms are linked to CD risk, current genetic markers lack predictive value for widespread occupational health use.
Area of Science:
- Dermatology
- Occupational Health
- Genetics
Background:
- Contact dermatitis (CD) is a common work-related illness impacting quality of life and work ability.
- CD includes allergic (ACD) and irritant (ICD) forms, with individual susceptibility varying under identical exposure conditions.
- Research is exploring genetic links to CD susceptibility, focusing on skin barrier, inflammation, and biotransformation genes.
Purpose of the Study:
- Investigate the association between genetic variations and individual susceptibility to occupational contact dermatitis.
- Identify specific genes and polymorphisms that may increase the risk of developing ICD and ACD.
- Evaluate the potential clinical utility of genetic markers in occupational health practice.
Main Methods:
- Review of recent studies examining gene variations related to skin barrier function (e.g., filaggrin).
- Analysis of research on inflammatory genes (e.g., TNFA-308 G/A polymorphism) and their association with CD.
- Examination of studies on biotransformation genes (e.g., N-acetyltransferases) and ACD risk.
Main Results:
- Loss-of-function mutations in filaggrin gene increase risk for ICD and nickel-related ACD, highlighting skin barrier importance.
- TNFA-308 G/A polymorphism is associated with susceptibility to both ICD and ACD.
- Polymorphisms in N-acetyltransferase genes modify sensitization risk to p-phenylenediamine in ACD.
Conclusions:
- Several genes involved in skin barrier, inflammation, and biotransformation are linked to occupational CD susceptibility.
- Current genetic markers have low predictive value for identifying susceptible individuals in occupational health.
- Larger cohorts and well-defined phenotypes are needed to confirm the impact of genetic variations on occupational CD risk.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:26Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...